Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally. Although several rapid commercial serological assays have been developed, little is known about their performance and accuracy in detecting SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashem, Anwar M., Alhabbab, Rowa Y., Algaissi, Abdullah, Alfaleh, Mohamed A., Hala, Sharif, Abujamel, Turki S., ElAssouli, M-Zaki, AL-Somali, Afrah A., Alofi, Fadwa S., Khogeer, Asim A., Alkayyal, Almohanad A., Mahmoud, Ahmad Bakur, Almontashiri, Naif A. M., Pain, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767212/
https://www.ncbi.nlm.nih.gov/pubmed/33352788
http://dx.doi.org/10.3390/pathogens9121067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767212/
https://www.ncbi.nlm.nih.gov/pubmed/33352788
http://dx.doi.org/10.3390/pathogens9121067

Ejemplares similares